None Volunteer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which None Volunteer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (8 shown)

CompletedNot Applicable

NCT01548625

Cardiovascular Effects of Incremental Diesel Exhaust Inhalation in Middle-Aged Healthy GSTM1 Null Human Volunteers

Purpose: A growing body of epidemiological data suggests an increased risk of cardiovascular events associated with air pollutants. Reactive oxygen species (ROS…

United States6 participantsStarted 2007-07

CompletedNot Applicable

NCT06624124

SimuVersity Medical Center: Pain and Opioid Management Training in Diverse Patient Populations

This study aims to compare the effectiveness of the new educational activity/game (a novel, engaging digital-training plus interaction with virtual patients to…

United States74 participantsStarted 2025-04-01

Treatment: Gamified Training in Diversity Considerations in the Management of Pain and Opioid Use, Traditional Training in Diversity Considerations in the Management of Pain and Opioid Use

Not Yet RecruitingNot Applicable

NCT06612658

Acute Effect of Capsimax on Resistance Exercise Performance, Muscle Oxygenation, Nitric Oxide Release, Resting Energy Ex…

Capsimax is a novel, proprietary encapsulated form of capsaicin, a natural and bioactive phytochemical found in chili pepper and other spicy food. The purpose o…

United States40 participantsStarted 2024-10-01

Treatment: A novel, proprietary encapsulated form of Capsicum extract in beadlet form standardized to 2% capsaicinoids

CompletedPhase 1

NCT01176851

Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers

The purpose of this study is to investigate the pharmacokinetics, the absolute bioavailability and the lung bioavailability of inhaled Glyco pMDI.

United Kingdom20 participantsStarted 2010-07

Treatment: Glycopyrrolate, Glycopyrrolate

UnknownPhase 4

NCT03249311

Levomilnacipran in Healthy Males

Levomilnacipran is an antidepressant currently approved in Canada to treat Major Depressive Disorder (MDD). Thirty-six healthy male participants will receive es…

Canada36 participantsStarted 2018-03-02

Treatment: Levomilnacipran, Duloxetine

CompletedNot Applicable

NCT00768573

Taste Test of a New Formulation of Sildenafil (Revatio)

taste of formulation

United States4 participantsStarted 2008-01

Treatment: sildenafil

CompletedPhase 1

NCT01568411

A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome…

This study will examine the effect of an inhibitor of cytochrome P450 isoenzyme 3A4 (CYP3A4) and permeability glycoprotein 1 (P gp) (200 mg itraconazole) on the…

United States20 participantsStarted 2012-04

Treatment: TD-1211, TD-1211+ itraconazole

CompletedPhase 1

NCT00774163

Safety of Lactobacillus Reuteri in Healthy Volunteers

This is a phase one study to assess the safety of daily dosing of Lactobacillus reuteri in healthy adults in Peru. It is conducted as a preliminary study in sup…

Peru45 participantsStarted 2010-02

Treatment: Lactobacillus reuteri, Placebo